IDSA on X: New in CID: A #dengue vaccine candidate was efficacious against symptomatic dengue in children and adolescents over 3 years post-vaccination across 8 endemic countries. 📄: #IDSAJournals #ClinInfectDis

Immune profile and responses of a novel dengue DNA vaccine

Is new dengue vaccine efficacy data a relief or cause for concern

Dengue vaccine: hypotheses to understand CYD-TDV-induced

Immunogenicity and safety of booster CYD-TDV dengue vaccine after

Dengue and Zika virus infections are enhanced by live attenuated

How the World's First Dengue Vaccination Drive Ended in Disaster

Dengue – the Region of the Americas

By Ahmed Khaled Vaccine team Pfizer KSA - ppt download

Opportunities for improved surveillance and control of dengue from

Is new dengue vaccine efficacy data a relief or cause for concern

Incidence of invasive pneumococcal disease in children with

VACCINE PREVENTABLE DISEASES AND VACCINATION - ppt download

Dengue pre-vaccination screening test evaluation for the use of

Four-year safety follow-up of the tetravalent dengue vaccine